Schedule 13G ownership disclosure

DIANTHUS THERAPEUTICS INC COM

Common Stock, par value $0.001 per share · CUSIP: 252828108

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Vestal Point Capital, LP

    Shares: 1,700,069.00 · Class: 5.3%

  • Ryan Wilder

    Shares: 1,700,069.00 · Class: 5.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000902664-25-002397
Form type
SCHEDULE 13G
Filer
Dianthus Therapeutics, Inc. /DE/
CIK
CIK 1690585
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub